Observations on the Food and Drug Administration advisory panel endovascular aortic repair report of type III endoleaks and the call for increased surveillance

J Vasc Surg. 2022 Jul;76(1):40-41. doi: 10.1016/j.jvs.2022.01.147.

Author

Gary W Lemmon¹

Affiliation

¹ Division of Vascular Surgery, Indiana University, Indianapolis, IN. Electronic address: gwlemmon@iu.edu.

PMID: 35738793
DOI: 10.1016/j.jvs.2022.01.147

No abstract available

Publication types

Editorial

MeSH terms

Aortic Aneurysm, Abdominal* / diagnostic imaging
Aortic Aneurysm, Abdominal* / surgery
Blood Vessel Prosthesis Implantation* / adverse effects
Endoleak / diagnostic imaging
Endoleak / etiology
Endovascular Procedures* / adverse effects
Humans
Retrospective Studies
Risk Factors
Treatment Outcome
United States
United States Food and Drug Administration